News | Radiation Therapy | October 29, 2018

RaySearch Demonstrates New Machine Learning Applications at ASTRO

Company showcases latest developments for treatment planning and oncology information systems

RaySearch Demonstrates New Machine Learning Applications at ASTRO

October 29, 2018 — RaySearch exhibited its latest advances in oncology software at the 2018 American Society for Radiation Oncology (ASTRO) annual meeting, Oct. 21-24 in San Antonio, Texas, backed by machine learning and user-friendly tools to enable optimal use of clinical resources. The company showed its latest development in machine learning technology and automation in both its RayStation treatment planning system (TPS) and RayCare oncology information system (OIS).

With its in-house machine learning department, RaySearch is currently developing machine learning and deep learning prototypes for areas such as treatment plan generation, organ segmentation and target volume estimation. RaySearch is also developing techniques for efficient large-scale data extraction and analysis. The first clinical applications of machine learning are automated treatment planning and automated organ segmentation and will be included in the next RayStation release in December.

The RayCare next-generation OIS is now directly connected to the treatment delivery system at the Provision Cares Proton Therapy facility in Nashville. RayCare is used to manage the radiation therapy treatment sessions. The Nashville center treated their first patient on Oct. 8 and utilizes the RayCare OIS together with the RayStation TPS to plan and manage its proton treatments.

RayCare 2B was released early October and was displayed at the show. This version introduces new features and usability improvements throughout the system, including a feature to support a full treatment delivery and management workflow and task-based offline image review. Other care administration features include support for financial information, such as insurance information and authorization management, and support for managing external contacts, referring clinicians and other external entities.

RaySearch also offered joint product demonstrations with other ASTRO 2018 exhibitors, including:

  • IBA and RaySearch presented their online adaptive proton therapy workflow, where daily optimized plans are created for the individual patient based on cone beam computed tomography (CBCT) images to preserve the original treatment intent. Both companies offered demonstrations including RayCare, RayStation, the AdaPT Insight imaging platform and the AdaPT Deliver treatment delivery. The solution can automatically suggest to the care team an adapted treatment plan that considers the most up-to-date patient anatomy. This workflow offers more accurate treatment plans as well as faster plan adaptation to the benefit of patients;
  • In the Accuray booth, presentations of RayStation and RayCare for the TomoTherapy platform were available. RayStation 8A, released earlier this summer, includes full support for the TomoTherapy and Radixact Systems. All TomoTherapy and Radixact users can now get access to advanced RayStation features, including multi-criteria optimization (MCO), adaptive planning and Plan Explorer; and
  • Mevion Medical Systems showed the latest proton therapy news with the Mevion S250i system with Hyperscan Pencil Beam Scanning demonstrations, using RayStation.

For more information: www.raysearchlabs.com

Related Content

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection
Technology | Computer-Aided Detection Software | May 21, 2019
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August...
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
AI Detects Unsuspected Lung Cancer in Radiology Reports, Augments Clinical Follow-up
News | Artificial Intelligence | May 20, 2019
Digital Reasoning announced results from its automated radiology report analytics research. In a series of experiments...
Brain images that have been pre-reviewed by the Viz.AI artificial intelligence software to identify a stroke. The software automatically sends and alert to the attending physician's smartphone with links to the imaging for a final human assessment to help speed the time to diagnosis and treatment. Depending on the type of stroke, quick action is needed to either activate the neuro-interventional lab or to administer tPA. Photo by Dave Fornell.

Brain images that have been pre-reviewed by the Viz.AI artificial intelligence software to identify a stroke. The software automatically sends and alert to the attending physician's smartphone with links to the imaging for a final human assessment to help speed the time to diagnosis and treatment. Depending on the type of stroke, quick action is needed to either activate the neuro-interventional lab or to administer tPA. Photo by Dave Fornell.

Feature | Artificial Intelligence | May 17, 2019 | Inga Shugalo
With its increasing role in medical imaging,...
FDA Clears Aidoc's AI Solution for Flagging Pulmonary Embolism
Technology | Artificial Intelligence | May 15, 2019
Artificial intelligence (AI) solutions provider Aidoc has been granted U.S. Food and Drug Administration (FDA)...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....